As Country President of Novartis Canada, Dimitri Gitas brings a global perspective and a clear focus on what matters most: helping Canadian patients benefit from medical innovation faster, more equitably and closer to home.

Explore recent interviews, op-eds and features where Dimitri shares perspectives on Canada’s life sciences sector, health equity, clinical research, women’s health and so much more on the partnerships needed to reimagine medicine for patients across the country.

Recent coverage

Opinion: Women’s health is not a niche issue, it’s a national health priority

Publication: Healthing.ca
August 10, 2026

Women’s health is central to the future of Canada’s healthcare system. In this opinion piece, Dimitri Gitas and Carmen Wyton make the case for treating women’s health as a national priority, linking earlier diagnosis, better access to care, health equity and system sustainability. 

The article highlights the need for stronger collaboration across governments, healthcare institutions, community organizations, patient groups and industry, while pointing to practical examples such as the Novartis Canada Health Equity Initiative. 

Read the Healthing.ca opinion article

Canada’s leadership in life sciences: access to innovation

Publication: BIOTECanada Insights Magazine, Spring 2026 edition
Date: Spring 2026

In BIOTECanada’s Spring 2026 edition of Insights, Dimitri Gitas reflects on Canada’s opportunity to strengthen its leadership in life sciences by turning scientific momentum into meaningful patient impact. 

The piece explores how Canada can build on its strengths in research, clinical excellence and breakthrough technologies, including radioligand therapy and precision medicine, while addressing a persistent challenge: helping patients access innovation reliably, equitably and on time. 

Visit BIOTECanada Insights Magazine

Premier Houston meets with Novartis Canada to discuss advancements in clinical research and patient access

Publication: Nova Scotia Health
Date: June 4, 2026

Nova Scotia Health highlighted a meeting between Premier Tim Houston and Dimitri Gitas at the Nova Scotia Health Innovation Hub, focused on clinical research, patient access and collaboration across government, healthcare and industry. 

The coverage features Novartis Canada’s partnership with the Innovation Hub and its role in helping bring clinical research closer to patients, strengthen Canada’s participation in global studies and support advances in areas such as breast cancer and prostate cancer. 

Read the Nova Scotia Health news release

The new era of life sciences

Publication: The Washington Post (Investment Reports Special Feature) and Investment Reports
Date: April 26, 2026

Dimitri Gitas was featured in The New Era of Life Sciences, a special report published by The Washington Post in partnership with Investment Reports. The feature brings together perspectives from global life sciences leaders on the future of healthcare innovation, including artificial intelligence, precision medicine, clinical research and patient access.

In his contribution, Dimitri highlights Canada's strengths in clinical research and innovation, as well as the importance of improving access to breakthrough medicines and strengthening the country's life sciences sector.

Read the feature in The Washington Post

Read the Investment Reports interview

Novartis Canada announces Dimitri Gitas as new Country President

Publication: Canadian Manufacturing
Date: November 25, 2025

Canadian Manufacturing covered Dimitri Gitas’ appointment as Country President of Novartis Canada.

The article introduces Dimitri’s leadership background across Canada, the United States, Greece, Poland and Switzerland and outlines his mandate to lead Novartis Canada’s strategy and operations across key therapeutic areas, including oncology, immunology, neuroscience and cardiovascular, renal and metabolic diseases. 

Read the Canadian Manufacturing article

Read more Novartis Canada news